10-Q.A – China Stock Advice

CPHI [CHINA PHARMA] 10-Q/A: (Original Filing)

[o Large accelerated filer] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321093015.htm]

By info| 2016-03-28T18:47:59+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: o Large accelerated filer

[o Large accelerated filer] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321093015.htm]

By info| 2016-03-28T18:49:11+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: (Original Filing)

[o Large accelerated filer o Accelerated filer o] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321063015.htm]

By info| 2016-03-28T18:50:31+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: o Large accelerated filer o Accelerated filer o

[o Large accelerated filer o Accelerated filer o] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321063015.htm]

By info| 2016-03-28T18:51:24+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: (Original Filing)

[o Large accelerated filer o Accelerated filer o Non-accelerated filer] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321033115.htm]

By info| 2016-03-28T18:52:38+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q/A: (Original Filing)

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this amendment to quarterly report on Form 10-Q for the period ended December 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this amendment to quarterly report on Form 10-Q for the period ended December 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q1214a1ex32i_tianyinphar.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Acting Chief Financial Officer EX-32.2 5 f10q1214a1ex32ii_tianyinphar.htm CERTIFICATION]

By info| 2016-03-19T14:14:49+00:00 August 20th, 2015|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 10-Q.A, 2015-08-20, 2834, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q/A:

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this amendment to quarterly report on Form 10-Q for the period ended December 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this amendment to quarterly report on Form 10-Q for the period ended December 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q1214a1ex32i_tianyinphar.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Acting Chief Financial Officer EX-32.2 5 f10q1214a1ex32ii_tianyinphar.htm CERTIFICATION]

By info| 2016-03-19T14:16:48+00:00 August 20th, 2015|Categories: Chinese Stocks, TPI, Webplus ver|Tags: 0001362718, 10-Q.A, 2015-08-20, 2834, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

IDI [IDI] 10-Q/A: (Original Filing)

[] [CERTIFICATIONS I, Peter W. H. Tan, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q/A of IDI, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, Derek Dubner, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q/A of IDI, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [CERTIFICATIONS I, Jacky Wang, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q/A of IDI, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of IDI, Inc. May 27, 2015 Peter W. H. Tan Co-Chief Executive Officer EX-32.1 5 d930922dex321.htm EX-32.1] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of IDI, Inc. May 27, 2015 Derek Dubner Co-Chief Executive Officer EX-32.2 6 d930922dex322.htm EX-32.2] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of IDI, Inc. May 27, 2015 Jacky Wang Chief Financial Officer (Principal Financial Officer) EX-32.3 7 d930922dex323.htm EX-32.3]

By info| 2016-03-13T16:02:06+00:00 May 27th, 2015|Categories: Chinese Stocks, IDI, SEC Original|Tags: 0001460329, 10-Q.A, 2015-05-27, 7310, IDI, SERVICES-ADVERTISING|0 Comments

IDI [IDI] 10-Q/A:

[] [CERTIFICATIONS I, Peter W. H. Tan, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q/A of IDI, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, Derek Dubner, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q/A of IDI, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [CERTIFICATIONS I, Jacky Wang, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q/A of IDI, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of IDI, Inc. May 27, 2015 Peter W. H. Tan Co-Chief Executive Officer EX-32.1 5 d930922dex321.htm EX-32.1] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of IDI, Inc. May 27, 2015 Derek Dubner Co-Chief Executive Officer EX-32.2 6 d930922dex322.htm EX-32.2] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of IDI, Inc. May 27, 2015 Jacky Wang Chief Financial Officer (Principal Financial Officer) EX-32.3 7 d930922dex323.htm EX-32.3]

By info| 2016-03-13T16:02:55+00:00 May 27th, 2015|Categories: Chinese Stocks, IDI, Webplus ver|Tags: 0001460329, 10-Q.A, 2015-05-27, 7310, IDI, SERVICES-ADVERTISING|0 Comments

CPGI [China Shengda Packaging] 10-Q/A: FORM 10Q/A (Mark One) [X] For the quarterly

[FORM 10Q/A (Mark One) [X] For the quarterly period ended: March 31, 2015 [ ] For the transition period from ____________ to _____________ CHINA SHENGDA PACKAGING GROUP INC. Nevada 26-1559574 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) No. 2 Beitang Road Peoples Republic of China Xiaoshan Economic and Technological Development Zone (86) 571-82838805 _____________________________________________________ Large] [CERTIFICATIONS I, Daliang Teng, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Shengda Packaging Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ken He, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Shengda Packaging Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Daliang Teng Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Ken He Chief Financial Officer (Principal Financial Officer)]

By info| 2016-03-31T03:33:15+00:00 May 26th, 2015|Categories: Chinese Stocks, CPGI, Webplus ver|Tags: 0001421561, 10-Q.A, 2015-05-26, 2650, CPGI, PAPERBOARD CONTAINERS and BOXES|0 Comments